News

The Center for American Indian and Alaska Native Diabetes Translation Research (CAIANDTR) seeks to translate research of proven efficacy into clinical and community settings, with the goal of improving prevention and treatment of diabetes in Native populations. The CAIANDTR Pilot & Feasibility Program is pleased to announce the availability of funding to support research consistent with this mission.

The Pilot & Feasibility Program provides support for early-stage investigators (ESIs) committed to conducting translational research related to diabetes in American Indian, Alaska Native, and Native Hawaiian (AI/AN/NH) populations.

During this 18-month research and training program, funded investigators will:

1. complete and publish a secondary analysis relevant to diabetes in AI/AN/NHs (Months 1-12) and
2. develop a grant application seeking larger-scale funding for their research efforts (Months 13-18).

Successful applications will be those that hold promise of benefiting Native people, are scientifically meritorious, are feasible within the time and resources available, and represent an early step in an innovative line of inquiry that can continue beyond this initial investment. CAIANDTR funding cannot be used to supplement funded research already in progress.

We are currently accepting pilot funding applications. Interest forms are due September 5, 2023. Complete applications are due September 18, 2023. 

View the full Request for Applications (RFA) information on our website or download the RFA.